Marvin 10230612332D 25 28 0 0 1 0 999 V2000 0.7145 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4290 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 -1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.4290 -1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.1434 -1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 2.9280 -0.1576 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 2.9280 -1.4925 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 3.4130 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4289 0.0000 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -2.1434 -1.2375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8579 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7145 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4289 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8579 -1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4289 -1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8579 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1434 1.2375 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.8579 -2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4289 -2.4750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1434 -2.8875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.1434 -3.7125 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 0.0000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -2.1434 -0.4125 0.0000 C 0 0 2 0 0 0 0 0 0 0 0 0 -2.8579 -0.8250 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0 23 1 1 0 0 0 0 1 2 1 0 0 0 0 1 3 2 0 0 0 0 2 4 2 0 0 0 0 3 5 1 0 0 0 0 4 6 1 0 0 0 0 4 7 1 0 0 0 0 6 8 1 0 0 0 0 7 9 1 0 0 0 0 5 6 2 0 0 0 0 8 9 1 0 0 0 0 24 10 1 0 0 0 0 24 11 1 0 0 0 0 24 12 1 0 0 0 0 10 13 1 1 0 0 0 10 14 1 0 0 0 0 11 15 1 0 0 0 0 11 16 2 0 0 0 0 12 17 1 0 0 0 0 14 18 1 0 0 0 0 15 19 2 0 0 0 0 16 20 1 0 0 0 0 17 18 1 0 0 0 0 19 21 1 0 0 0 0 20 21 2 0 0 0 0 21 22 1 0 0 0 0 23 13 1 0 0 0 0 24 25 1 1 0 0 0 M END > CHEBI:7936 > paroxetine > A benzodioxole that consists of piperidine bearing 1,3-benzodioxol-5-yloxy)methyl and 4-fluorophenyl substituents at positions 3 and 4 respectively; the (3S,4R)-diastereomer. Highly potent and selective 5-HT uptake inhibitor that binds with high affinity to the serotonin transporter (Ki = 0.05 nM). Ki values are 1.1, 350 and 1100 nM for inhibition of [3H]-5-HT, [3H]-l-NA and [3H]-DA uptake respectively. Displays minimal affinity for ?1-, ?2- or ?-adrenoceptors, 5-HT2A, 5-HT1A, D2 or H1 receptors at concentrations below 1000 nM, however displays weak affinity for muscarinic ACh receptors (Ki = 42 nM). Antidepressant and anxiolytic in vivo. > 3 > Paroxetine; (3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine; (-)-(3S,4R)-4-(p-fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine > (3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine > paroxetinum; paroxetina > C19H20FNO3 > 329.36540 > 329.14272 > 0 > [H][C@]1(CCNC[C@H]1COc1ccc2OCOc2c1)c1ccc(F)cc1 > InChI=1S/C19H20FNO3/c20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18/h1-6,9,14,17,21H,7-8,10-12H2/t14-,17-/m0/s1 > AHOUBRCZNHFOSL-YOEHRIQHSA-N > 7467879 > 61869-08-7 > 7467879 > 61869-08-7 > DB00715 > C07415 > D02362 > LSM-2843 > Paroxetine > 11009210; 11169163; 11271409; 11281965; 11324355; 11360029; 11513198; 11563413; 11565622; 11819027; 11893234; 11910269; 12027788; 12088162; 12369443; 12421645; 12818234; 12820211; 12906023; 12920419; 14516531; 14521492; 14566196; 14566200; 14619895; 14624192; 14673053; 14689334; 14978354; 15048901; 15199661; 15241233; 15264994; 15374134; 15376524; 15544025; 15613191; 15845695; 15853570; 15903129; 15963219; 15992089; 16395417; 16397315; 16426087; 16765127; 16822276; 16913391; 17122538; 17162096; 17219219; 17286545; 17452166; 17559097; 17612590; 17652957; 17874333; 18273418; 18345955; 18808757; 18983224; 19687003; 19851065; 21404089; 21452176; 21739267; 21908494; 21909633; 21922171; 21939725; 22153922; 22198456; 22212003; 22240860; 22263916; 22283559; 22353759; 22377745 $$$$